Glecaprevir/pibrentasvir is effective and well tolerated in individuals with hepatitis C

(Spink Health) Two large 'real-world' studies conducted in Germany and the USA have confirmed the high rates of sustained virological response (SVR) observed in controlled clinical studies of glecaprevir/pibrentasvir (G/P) involving individuals with hepatitis C virus (HCV) infection.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news